Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Min Chul Cho & Jae-Seung Paick. (2014) Udenafil for the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management 10, pages 341-354.
Read now
Read now
Grant P Redrow, Chad M Thompson & Run Wang. (2014) Treatment strategies for diabetic patients suffering from erectile dysfunction: an update. Expert Opinion on Pharmacotherapy 15:13, pages 1827-1836.
Read now
Read now
Yun Chen, Yutian Dai & Run Wang. (2008) Treatment strategies for diabetic patients suffering from erectile dysfunction. Expert Opinion on Pharmacotherapy 9:2, pages 257-266.
Read now
Read now
Articles from other publishers (19)
Asra K. Butt, Jay Patel, Hamid Shirwany, Qasim Mirza, Jonathan Hoover & Rami N. Khouzam. (2022) Beneficial Extracardiac Effects of Cardiovascular Medications. Current Cardiology Reviews 18:2.
Crossref
Crossref
Vladimir Bykov, Evgenia Gushchina, Sergey Morozov, Natalia Zhuravskaya, Kirill Kryshen, Valery Makarov, Aleksandr Matichin & Alena Zueva. (2022) Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction. Sexual Medicine 10:1, pages 100477-1.
Crossref
Crossref
Arthur L. Burnett, Ajay Nehra, Rodney H. Breau, Daniel J. Culkin, Martha M. Faraday, Lawrence S. Hakim, Joel Heidelbaugh, Mohit Khera, Kevin T. McVary, Martin M. Miner, Christian J. Nelson, Hossein Sadeghi-Nejad, Allen D. Seftel & Alan W. Shindel. (2018) Erectile Dysfunction: AUA Guideline. Journal of Urology 200:3, pages 633-641.
Crossref
Crossref
Ercan Ogreden, Ural Oğuz, Erhan Demirelli, Alptekin Tosun & Orhan Yalçın. (2018) Relationship between Response to PDE5 Inhibitors and Penile Duplex Doppler Ultrasound in Erectile Dysfunction. Medical Sciences 6:2, pages 28.
Crossref
Crossref
Istvan Kovanecz, Dolores Vernet, Maryam Masouminia, Robert Gelfand, Leila Loni, James Aboagye, James Tsao, Jacob Rajfer & Nestor F. Gonzalez-Cadavid. (2016) Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu. The Journal of Sexual Medicine 13:5, pages 786-797.
Crossref
Crossref
Min Chul Cho & Jae-Seung Paick. (2016) A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction. Therapeutic Advances in Urology 8:2, pages 100-117.
Crossref
Crossref
Giuseppe Defeudis, Daniele Gianfrilli, Chiara Di Emidio, Riccardo Pofi, Dario Tuccinardi, Andrea Palermo, Andrea Lenzi & Paolo Pozzilli. (2015) Erectile dysfunction and its management in patients with diabetes mellitus. Reviews in Endocrine and Metabolic Disorders 16:3, pages 213-231.
Crossref
Crossref
Richard E. Scranton, Irwin Goldstein & Vera J. Stecher. (2013) Erectile Dysfunction Diagnosis and Treatment as a Means to Improve Medication Adherence and Optimize Comorbidity Management. The Journal of Sexual Medicine 10:2, pages 551-561.
Crossref
Crossref
Y Chen, S Cui, H Lin, Z Xu, W Zhu, L Shi, R Yang, R Wang & Y Dai. (2012) Losartan improves erectile dysfunction in diabetic patients: a clinical trial. International Journal of Impotence Research 24:6, pages 217-220.
Crossref
Crossref
K. Park, S. Y. Cho & S. W. Kim. (2011) Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes. International Journal of Andrology 34:5pt2, pages e468-e474.
Crossref
Crossref
Lu Luo, De-Zai Dai, Yu-Si Cheng, Qi Zhang, Wen-Jun Yuan & Yin Dai. (2011) Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats. Journal of Pharmacy and Pharmacology 63:7, pages 943-951.
Crossref
Crossref
V V Rafal'skiĭ & A N Baglikov. (2010) Approaches to the rational choice of type 5 phosphodiesterase inhibitors in patients presenting with cardiovascular and endocrine diseases. Problems of Endocrinology 56:6, pages 63-72.
Crossref
Crossref
Giovanni Pennisi, Marco Vacante, Cristina Russo & Mariano Malaguarnera. (2010) Rhabdomyolysis Induced by Rosuvastatin and Sildenafil. Southern Medical Journal 103:10, pages 1052-1054.
Crossref
Crossref
Hyun Jun Park, Hyung Ki Choi, Tai Young Ahn, Jong Kwan Park, Woo Sik Chung, Sung Won Lee, Sae Woong Kim, Jae Seog Hyun & Nam Cheol Park. (2010) Efficacy and Safety of Oral Mirodenafil in the Treatment of Erectile Dysfunction in Diabetic Men in Korea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The Journal of Sexual Medicine 7:8, pages 2842-2850.
Crossref
Crossref
F. Giuliano, G. Jackson, F. Montorsi, A. Martin-Morales & P. Raillard. (2009) Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. International Journal of Clinical Practice 64:2, pages 240-255.
Crossref
Crossref
R. Sadovsky, G. B. Brock, S. W. Gutkin & S. Sorsaburu. (2009) Toward a new ‘EPOCH’: optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction. International Journal of Clinical Practice 63:8, pages 1214-1230.
Crossref
Crossref
Alan M. Laties. (2009) Vision Disorders and Phosphodiesterase Type 5 Inhibitors. Drug Safety 32:1, pages 1-18.
Crossref
Crossref
Martin Miner, Larry Gilderman, James Bailen, David Cook, Katie Dawson, Marisha Stanislaus, Eric Beresford & Allison Barnes. (2008) Vardenafil in Men with Stable Statin Therapy and Dyslipidemia. The Journal of Sexual Medicine 5:6, pages 1455-1467.
Crossref
Crossref
Garry Welch, Alan Jacobson & Katie Weinger. 2007. Type 2 Diabetes. Type 2 Diabetes
83
95
.